↓ Skip to main content

Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?

Overview of attention for article published in Frontiers in oncology, June 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
5 X users
reddit
1 Redditor

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Does Pathologic Response Equate to Clinical Response Following SABR for Early-Stage NSCLC?
Published in
Frontiers in oncology, June 2019
DOI 10.3389/fonc.2019.00551
Pubmed ID
Authors

Eric D. Brooks, Vivek Verma, Joe Y. Chang

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 21%
Student > Doctoral Student 1 7%
Lecturer 1 7%
Researcher 1 7%
Professor > Associate Professor 1 7%
Other 0 0%
Unknown 7 50%
Readers by discipline Count As %
Medicine and Dentistry 2 14%
Physics and Astronomy 1 7%
Nursing and Health Professions 1 7%
Unknown 10 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2023.
All research outputs
#8,115,271
of 26,255,623 outputs
Outputs from Frontiers in oncology
#2,867
of 22,954 outputs
Outputs of similar age
#134,135
of 370,671 outputs
Outputs of similar age from Frontiers in oncology
#62
of 296 outputs
Altmetric has tracked 26,255,623 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 22,954 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 370,671 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 296 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.